Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy
Background. Hepatic ischemia-reperfusion (I/R) injury is a pivotal clinical problem occurring in many clinical conditions such as transplantation, trauma, and hepatic failure after hemorrhagic shock. Apoptosis and autophagy have been shown to contribute to cell death in hepatic I/R injury. Ethyl pyr...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/461536 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832548030164762624 |
---|---|
author | Miao Shen Jie Lu Weiqi Dai Fan Wang Ling Xu Kan Chen Lei He Ping Cheng Yan Zhang Chengfen Wang Dong Wu Jing Yang Rong Zhu Huawei Zhang Yinqun Zhou Chuanyong Guo |
author_facet | Miao Shen Jie Lu Weiqi Dai Fan Wang Ling Xu Kan Chen Lei He Ping Cheng Yan Zhang Chengfen Wang Dong Wu Jing Yang Rong Zhu Huawei Zhang Yinqun Zhou Chuanyong Guo |
author_sort | Miao Shen |
collection | DOAJ |
description | Background. Hepatic ischemia-reperfusion (I/R) injury is a pivotal clinical problem occurring in many clinical conditions such as transplantation, trauma, and hepatic failure after hemorrhagic shock. Apoptosis and autophagy have been shown to contribute to cell death in hepatic I/R injury. Ethyl pyruvate, a stable and simple lipophilic ester, has been shown to have anti-inflammatory properties. In this study, the purpose is to explore both the effect of ethyl pyruvate on hepatic I/R injury and regulation of intrinsic pathway of apoptosis and autophagy.
Methods. Three doses of ethyl pyruvate (20 mg/kg, 40 mg/kg, and 80 mg/kg) were administered 1 h before a model of segmental (70%) hepatic warm ischemia was established in Balb/c mice. All serum and liver tissues were obtained at three different time points (4 h, 8 h, and 16 h).
Results. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and pathological features were significantly ameliorated by ethyl pyruvate (80 mg/kg). The expression of Bcl-2, Bax, Beclin-1, and LC3, which play an important role in the regulation of intrinsic pathway of apoptosis and autophagy, was also obviously decreased by ethyl pyruvate (80 mg/kg). Furthermore, ethyl pyruvate inhibited the HMGB1/TLR4/ NF-κb axis and the release of cytokines (TNF-α and IL-6).
Conclusion. Our results showed that ethyl pyruvate might attenuate to hepatic I/R injury by inhibiting intrinsic pathway of apoptosis and autophagy, mediated partly through downregulation of HMGB1/TLR4/ NF-κb axis and the competitive interaction with Beclin-1 of HMGB1. |
format | Article |
id | doaj-art-04321f799a1e4a4299399d4bcc48bf3e |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-04321f799a1e4a4299399d4bcc48bf3e2025-02-03T06:42:17ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/461536461536Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and AutophagyMiao Shen0Jie Lu1Weiqi Dai2Fan Wang3Ling Xu4Kan Chen5Lei He6Ping Cheng7Yan Zhang8Chengfen Wang9Dong Wu10Jing Yang11Rong Zhu12Huawei Zhang13Yinqun Zhou14Chuanyong Guo15Department of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaDepartment of Gastroenterology, The Tenth People's Hospital of Tongji University, Shanghai 200072, ChinaBackground. Hepatic ischemia-reperfusion (I/R) injury is a pivotal clinical problem occurring in many clinical conditions such as transplantation, trauma, and hepatic failure after hemorrhagic shock. Apoptosis and autophagy have been shown to contribute to cell death in hepatic I/R injury. Ethyl pyruvate, a stable and simple lipophilic ester, has been shown to have anti-inflammatory properties. In this study, the purpose is to explore both the effect of ethyl pyruvate on hepatic I/R injury and regulation of intrinsic pathway of apoptosis and autophagy. Methods. Three doses of ethyl pyruvate (20 mg/kg, 40 mg/kg, and 80 mg/kg) were administered 1 h before a model of segmental (70%) hepatic warm ischemia was established in Balb/c mice. All serum and liver tissues were obtained at three different time points (4 h, 8 h, and 16 h). Results. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), and pathological features were significantly ameliorated by ethyl pyruvate (80 mg/kg). The expression of Bcl-2, Bax, Beclin-1, and LC3, which play an important role in the regulation of intrinsic pathway of apoptosis and autophagy, was also obviously decreased by ethyl pyruvate (80 mg/kg). Furthermore, ethyl pyruvate inhibited the HMGB1/TLR4/ NF-κb axis and the release of cytokines (TNF-α and IL-6). Conclusion. Our results showed that ethyl pyruvate might attenuate to hepatic I/R injury by inhibiting intrinsic pathway of apoptosis and autophagy, mediated partly through downregulation of HMGB1/TLR4/ NF-κb axis and the competitive interaction with Beclin-1 of HMGB1.http://dx.doi.org/10.1155/2013/461536 |
spellingShingle | Miao Shen Jie Lu Weiqi Dai Fan Wang Ling Xu Kan Chen Lei He Ping Cheng Yan Zhang Chengfen Wang Dong Wu Jing Yang Rong Zhu Huawei Zhang Yinqun Zhou Chuanyong Guo Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy Mediators of Inflammation |
title | Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy |
title_full | Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy |
title_fullStr | Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy |
title_full_unstemmed | Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy |
title_short | Ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy |
title_sort | ethyl pyruvate ameliorates hepatic ischemia reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy |
url | http://dx.doi.org/10.1155/2013/461536 |
work_keys_str_mv | AT miaoshen ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT jielu ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT weiqidai ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT fanwang ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT lingxu ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT kanchen ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT leihe ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT pingcheng ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT yanzhang ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT chengfenwang ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT dongwu ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT jingyang ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT rongzhu ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT huaweizhang ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT yinqunzhou ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy AT chuanyongguo ethylpyruvateameliorateshepaticischemiareperfusioninjurybyinhibitingintrinsicpathwayofapoptosisandautophagy |